Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype
Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype
复制标题
DOI:
10.1158/0008-5472.can-05-1666
复制
发表时间:
2005-12-01
期刊:
影响因子:
11.2
通讯作者:
Mudryj, M
中科院分区:
文献类型:
--
作者:
Libertini, SJ;Robinson, BS;Mudryj, M
Overexpression of cyclin E in breast tumors is associated with a poor response to tamoxifen therapy, greater genomic instability, more aggressive behavior, and a poor clinical prognosis. These tumors also express low molecular weight isoforms of cyclin E that are associated with higher kinase activity and increased metastatic potential. In the current study, we show that cyclin E overexpression in MCF7 cells transactivates the expression of calpain 2, leading to proteolysis of cyclin E as well as several known calpain substrates including focal adhesion kinase (FAK), calpastatin, pp60src, and p53. In vivo inhibition of calpain activity in MCF7-cyclin E cells impedes cyclin E proteolysis, whereas in vivo induction of calpain activity promotes cyclin E proteolysis. An analysis of human breast tumors shows that high levels of cyclin E are coincident with the expression of the low molecular weight isoforms, high levels of calpain 2 protein, and proteolysis of FAK. Lastly, studies using a mouse model of metastasis reveal that highly metastatic tumors express proteolyzed cyclin E and FAK when compared to tumors with a low metastatic potential. Our results suggest that cyclin E-dependent deregulation of calpain may be pivotal in modifying multiple cellular processes that are instrumental in the etiology and progression of breast cancer. (Cancer Res 2005; 65(23): 10700-8).